跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31 条关于
“neuroplastogen”
全部
31
临床试验
0
药物
0
机构
0
资讯
31
22天前
Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, to Lead Phase 1 Trial of Neuroplastogen PSIL-006
去年
BetterLife Pharma's BETR-001 Shows Promise as Non-Hallucinogenic Neuroplastogen for Psychiatric Disorders
去年
Enveric Biosciences to Divest PsyAI Trademark, Focuses on Novel Neuroplastogen Development
3个月前
Delix Therapeutics' Novel Neuroplastogen Zalsupindole Shows No Cognitive Impairment in Phase 1b Depression Trial
去年
Elkedonia Raises €11.25 Million to Develop Novel Neuroplastogen Therapy for Treatment-Resistant Depression
4个月前
DemeRx Receives FDA Clearance for Novel Neuroplastogen DMX-1001 to Treat Alcohol Use Disorder
6天前
Lilly Closes $2.8B AtaiBeckley Acquisition, Adding Rapid-Acting Neuroplastogen BPL-003 for Treatment-Resistant Depression
9个月前
Enveric Biosciences Secures Fourth Patent for Non-Hallucinogenic Neuroplastogenic Drug Candidates
去年
Enveric Biosciences' EB-003 Shows Statistically Significant Antidepressant Effects in Preclinical Depression Model
去年
Psilera Partners with Hesperos to Advance Organ-on-a-Chip Testing for Frontotemporal Dementia Drug
第 1 页,共 4 页
上一页
下一页